Data / Form D filings / CoRegen, Inc.
CoRegen, Inc.: Form D filings
CoRegen, Inc., a biotechnology company in Houston, TX, filed 6 Form D notices with the SEC between 2024 and 2026. The latest, on February 26, 2026, reports $13.5 million sold of a $13.5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 801 TRAVIS STREET SUITE 2101, Houston, TX, 77002
- Phone
- (858) 232-5241
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2012886
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | New notice | $13,500,000 | $13,500,000 | 1 | Oct 28, 2025 | sec.gov | |
| May 22, 2025 | New notice | $62,640,000 | $62,640,000 | 8 | Apr 21, 2025 | sec.gov | |
| Feb 28, 2025 | New notice | $10,000,002 | $10,000,002 | 1 | Feb 3, 2025 | sec.gov | |
| Feb 28, 2025 | New notice | $20,750,000 | $20,750,000 | 7 | Jan 19, 2025 | sec.gov | |
| Mar 8, 2024 | New notice | $12,870,000 | $12,870,000 | 31 | Aug 9, 2022 | sec.gov | |
| Feb 22, 2024 | New notice | Indefinite | $14,500,000 | 1 | Feb 8, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steve Gorlin | Executive Officer, Director | President and Vice Chairman of the Board |
| Sonal Gupta | Executive Officer | |
| Sonja Nelson | Executive Officer | Chief Financial Officer and Secretary |
| Bert W. O'Malley | Director | |
| Edward J. Benz, Jr. | Director | |
| Suneet Varma | Director | |
| Lee Fleisher | Director | |
| William Haseltine, PhD. | Director | |
| Jonathan W. Simons | Director | |
| Peter Gelinas | Executive Officer |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Feb 23, 2026 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CoRegen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.